FD74974F4C8FCD87EC85327880D51E54393242F33CC8C50174253511F5677E08A2DE0753385395D2B13E266D21E04083

Defects in SLC25A20 are the cause of carnitine-acylcarnitine translocase deficiency (CACT deficiency) [MIM:212138]. It is an autosomal recessive deficiency in mitochondrial oxidation of fatty acids. It is usually lethal within a few hours or days after birth. Symptoms characterizing its normally severe clinical phenotype include fatty hepatomegaly with abnormal liver function, cardiomyopathy, muscle weakness and episodes of life-threatening coma, which eventually lead to death.

Source:http://purl.uniprot.org/SHA-384/FD74974F4C8FCD87EC85327880D51E54393242F33CC8C50174253511F5677E08A2DE0753385395D2B13E266D21E04083

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
rdfs:comment
Defects in SLC25A20 are the cause of carnitine-acylcarnitine translocase deficiency (CACT deficiency) [MIM:212138]. It is an autosomal recessive deficiency in mitochondrial oxidation of fatty acids. It is usually lethal within a few hours or days after birth. Symptoms characterizing its normally severe clinical phenotype include fatty hepatomegaly with abnormal liver function, cardiomyopathy, muscle weakness and episodes of life-threatening coma, which eventually lead to death.